Evidence map›Paper›PMID 40960299›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2025

From Guidelines to Real-Time Conversation: Expert-Validated Retrieval-Augmented and Fine-Tuned GPT-4 for Hepatitis C Management.

Mauro Giuffrè, Nicola Pugliese, Simone Kresevic, Milos Ajcevic, Francesco Negro, Massimo Puoti, Xavier Forns, Jean-Michel Pawlotsky, Dennis L Shung, Alessio Aghemo

Abstract read
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. From Guidelines to Real-Time Conversation: Expert-Validated Retrieval-Augmented and Fine-Tuned GPT-4 for Hepatitis C Management.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mauro GiuffrèDepartment of Internal Medicine (Section of Digestive Diseases), Yale School of Medicine, Yale University, New Haven, Connecticut, USA.ORCID 0000-0002-9910-3514
Nicola PuglieseDepartment of Biomedical Sciences, Humanitas University, Milano, Italy.
Simone KresevicDepartment of Engineering and Architecture, University of Trieste, Trieste, Italy.
Milos AjcevicDepartment of Engineering and Architecture, University of Trieste, Trieste, Italy.
Francesco NegroDivision of Gastroenterology, University Hospitals of Geneva, Geneva, Switzerland.
Massimo PuotiDivision of Infectious Diseases, ASST GOM Niguarda, Milan, Italy.ORCID 0000-0003-3278-7138
Xavier FornsLiver Unit, Hospital Clínic, University of Barcelona, IDIBAPS, Barcelona, Spain.
Jean-Michel PawlotskyUniversité Paris Est Créteil, INSERM, IMRB, Créteil, France.ORCID 0000-0003-0745-7559
Dennis L ShungDepartment of Internal Medicine (Section of Digestive Diseases), Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Alessio AghemoDepartment of Biomedical Sciences, Humanitas University, Milano, Italy.ORCID 0000-0003-0941-3226

Funding

Deep Learning Approaches to Risk Stratification in Acute Gastrointestinal BleedingK23DK125718 · NIDDK · YALE UNIVERSITY · PI SHUNG, DENNIS · 2021 to 2025
$969k
NIDDK NIH HHS K23 DK125718NIH HHS DK125718
6 · The paper itself

Abstract

BACKGROUND AND

aimsAdvances in artificial intelligence, particularly large language models (LLMs), hold promise for transforming chronic disease management such as Hepatitis C Virus (HCV) infection. This study evaluates the impact of retrieval-augmented generation (RAG) and supervised fine-tuning (SFT) on both open-ended question answering (accuracy and clarity) and on LLM-recommended treatment regimens for clinical scenarios.

methodsWe employed OpenAI's GPT-4 Turbo in four configurations-baseline, RAG-Top1, RAG-Top 10 and SFT-using the 2020 EASL HCV guidelines as external knowledge or fine-tuning data. For the question set, guidelines were segmented at the paragraph level and encoded into 3072-dimensional embeddings. Fifteen questions covering general, patient and physician perspectives were scored on a 10-point accuracy scale and binary accuracy/clarity by four experts. Separately, we created 25 simulated clinical scenarios; a consensus of four hepatologists defined the gold-standard DAA regimens. Model performance on these cases was measured by two metrics: 'partial accuracy' (≥ one correct DAA without errors) and 'complete accuracy' (all correct DAAs without errors).

resultsOn open-ended questions, RAG-Top10 outperformed baseline in accuracy (91.7% vs. 36.6%; p < 0.001) and clarity (91.7% vs. 46.6%; p < 0.001). RAG-Top1 achieved 81.7% accuracy and 86.6% clarity (both p < 0.001), while SFT reached 71.7% accuracy and 88.3% clarity (p < 0.001). Similarly, RAG-Top10 achieved the highest performance in prescribing the correct DAA regimen according to expert consensus in 76% of cases (vs. 24% for baseline model, p < 0.001).

conclusionsBoth RAG-Top10 and SFT markedly enhance LLM performance in guideline-driven HCV management-improving not only response accuracy and clarity but also DAA selection in clinical scenarios. RAG-Top10's broader context retrieval confers the greatest gains, while SFT underscores the value of domain-specific alignment. Rigorous, expert-informed evaluation frameworks are essential for the safe integration of LLMs into clinical practice.

Indexed as

Antiviral AgentsArtificial IntelligenceHepatitis C, ChronicPractice Guidelines as TopicHumansAntiviral AgentsChatGPTgenerative artificial intelligencegenerative pretrained modelshepatitis C viruslarge language models

Identifiers

PMID40960299
PMCPMC12442523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.